Toll interacting protein (TOLLIP) gene polymorphisms in patients with systemic sclerosis (SSc) associated interstitial lung disease (ILD): association with outcome and survival

被引：0
|
作者：
Schroeder, Niels [1 ]
Andrae, Jitka [1 ]
Knuth-Rehr, Diana [2 ]
Leja, Silke [2 ]
Hunzelmann, Nicolas [2 ]
Boerner, Eda [1 ]
Bonella, Francesco [1 ]
机构：
[1] Univ Duisburg Essen, Pneumonol Dept, Ctr Interstitial & Rare Lung Dis, Ruhrlandklin, Essen, Germany
[2] Univ Hosp Cologne, Dept Dermatol & Venereol, Cologne, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4261
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON
    Allanore, Yannick
    Vonk, Madelon
    Azuma, Arata
    Mayes, Maureen
    Gahlemann, Martina
    James, Alexandra
    Kohlbrenner, Veronika
    Stowasser, Susanne
    Highland, Kristin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [42] Effect of Nintedanib in Patients with Systemic Sclerosis- Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline
    Wells, A. U.
    Highland, K. B.
    Glaeser, S.
    Nunes, H.
    Song, J. W.
    Wuyts, W. A.
    Stock, C.
    Alves, M.
    Padilla, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [43] BASELINE CHARACTERISTICS OF PATIENTS WITH IMPROVEMENT OR PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) DURING THE SENSCIS TRIAL
    Hoffmann-Vold, A. M.
    Hachulla, E.
    Herrick, A.
    Moua, T.
    Riemekasten, G.
    Vonk, M.
    James, A.
    Alves, M.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 720 - 720
  • [44] Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
    Reyes, Felipe
    Saavedra, Silvana
    Vergara, Karen
    Wurmann, Pamela
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [45] Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
    Fields, Aislin
    Potel, Koray N.
    Cabuhal, Rhandel
    Aziri, Buena
    Stewart, Iain D.
    Schock, Bettina C.
    THORAX, 2023, 78 (08) : 799 - 807
  • [46] Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
    Khedoe, Padmini
    Marges, Emiel
    Hiemstra, Pieter
    Ninaber, Maarten
    Geelhoed, Miranda
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [47] Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD)
    Al-Adwi, Yehya
    Westra, Johanna
    van Goor, Harry
    van Kempen, Leon C.
    Osman, Mohammed
    Gan, C. Tji
    Timens, Wim
    Mulder, Douwe J.
    JOURNAL OF AUTOIMMUNITY, 2024, 148
  • [48] Lung Function And Survival In Systemic Sclerosis Associated Interstitial Lung Disease
    Shadly, S. M.
    Johnson, S. R.
    Chau, C.
    Marras, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [49] MYCOPHENOLATE MOPHETIL IN THE TREATMENT OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSC-ILD) IN PATIENTS UNRESPONSIVE TO CYCLOPHOSPHAMIDE (CYC)
    Cuomo, G.
    Abignano, G.
    Iudici, M.
    Petrillo, A.
    Valentini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S167 - S167
  • [50] Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial
    Goh, N.
    Denton, C. P.
    Lynch, D. A.
    Maher, T. M.
    Smith, V.
    Prasse, A.
    Cottin, V.
    Spiera, R.
    Stock, C.
    Gahlemann, M.
    Alves, M.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345